Dr. Jonathan Silverberg Lists Which Patients With AD Benefit Most From JAK Inhibitors

Jonathan Silverberg, MD, PhD, MPH, of George Washington University School of Medicine and Health Sciences, explains the benefits of using Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD). To read more, please click here.

Latest News

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce the selection of Karen A. Fagan, MD, to serve as the Chair of the GW Department of Medicine.
Frequent interruptions to sleep and daytime sleepiness may be indicative of sleep apnea and warrant a consultation with a sleep expert.
The GW Medical Faculty Associates’ Department of Medicine has tapped Nadine El Asmar, MD, to serve as the interim Director of the Division of Endocrinology and Metabolism.